IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 114 filers reported holding IRADIMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,364,965 | -6.6% | 53,301 | +0.5% | 0.01% | 0.0% |
| Q2 2023 | $2,531,270 | +18.4% | 53,022 | -2.4% | 0.01% | +11.1% |
| Q1 2023 | $2,137,492 | +491.9% | 54,320 | +325.5% | 0.01% | +350.0% |
| Q4 2022 | $361,150 | +24.5% | 12,766 | +32.3% | 0.00% | 0.0% |
| Q3 2022 | $290,000 | +16.9% | 9,646 | +32.0% | 0.00% | +100.0% |
| Q2 2022 | $248,000 | -26.4% | 7,306 | -2.7% | 0.00% | 0.0% |
| Q1 2022 | $337,000 | -51.6% | 7,506 | -50.2% | 0.00% | -66.7% |
| Q4 2021 | $697,000 | +37.5% | 15,086 | 0.0% | 0.00% | +50.0% |
| Q3 2021 | $507,000 | +4.1% | 15,086 | -8.9% | 0.00% | 0.0% |
| Q2 2021 | $487,000 | +10.2% | 16,556 | -3.4% | 0.00% | 0.0% |
| Q1 2021 | $442,000 | +7.3% | 17,146 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $412,000 | -1.4% | 18,086 | -7.4% | 0.00% | 0.0% |
| Q3 2020 | $418,000 | – | 19,536 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Ten Capital Management LLC | 783,066 | $30,814,000 | 5.13% |
| Soleus Capital Management, L.P. | 773,694 | $30,444,859 | 3.15% |
| RK Capital | 335,400 | $13,197,990 | 2.90% |
| Capital Impact Advisors, LLC | 19,390 | $762,997 | 0.94% |
| Ranger Investment Management | 205,692 | $8,093,980 | 0.54% |
| Bares Capital Management | 317,000 | $12,473,950 | 0.44% |
| Hillsdale Investment Management Inc. | 109,100 | $4,293,085 | 0.37% |
| CORNERCAP INVESTMENT COUNSEL INC | 37,007 | $1,456,225 | 0.26% |
| Riverwater Partners LLC | 6,234 | $245,308 | 0.22% |
| RICE HALL JAMES & ASSOCIATES, LLC | 72,271 | $2,843,864 | 0.16% |